Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in CashChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Silence Therapeutics (SLN) Cash from Financing Activities (2020 - 2025)

Silence Therapeutics' Cash from Financing Activities history spans 6 years, with the latest figure at $1000.0 for Q2 2025.

  • On a quarterly basis, Cash from Financing Activities fell 99.91% to $1000.0 in Q2 2025 year-over-year; TTM through Dec 2025 was $15000.0, a 99.99% decrease, with the full-year FY2025 number at $15000.0, down 99.99% from a year prior.
  • Cash from Financing Activities hit $1000.0 in Q2 2025 for Silence Therapeutics, down from $14000.0 in the prior quarter.
  • Over the last five years, Cash from Financing Activities for SLN hit a ceiling of $133.0 million in Q1 2024 and a floor of -$98000.0 in Q4 2024.
  • Historically, Cash from Financing Activities has averaged $15.7 million across 5 years, with a median of $585897.9 in 2021.
  • The widest YoY moves for Cash from Financing Activities: up 575876.78% in 2024, down 100.8% in 2024.
  • Tracing SLN's Cash from Financing Activities over 5 years: stood at $585897.9 in 2021, then crashed by 91.19% to $51608.8 in 2022, then soared by 23756.81% to $12.3 million in 2023, then crashed by 100.8% to -$98000.0 in 2024, then surged by 101.02% to $1000.0 in 2025.
  • Business Quant data shows Cash from Financing Activities for SLN at $1000.0 in Q2 2025, $14000.0 in Q1 2025, and -$98000.0 in Q4 2024.